Atlas Trials

Congenital Amegakaryocytic Thrombocytopenia

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Congenital Amegakaryocytic Thrombocytopenia

RecordFirmDate
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) (NCT04965597)Fred Hutchinson Cancer Center2022-04-19
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer (NCT03333486)Roswell Park Cancer Institute2017-12-07
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01529827)Roswell Park Cancer Institute2012-02-28
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease (NCT00295971)University of California, San Francisco2005-04-01
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders (NCT00301834)University of California, San Francisco2005-01-01
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission (NCT00305708)University of California, San Francisco2000-08-01

Track Congenital Amegakaryocytic Thrombocytopenia automatically

Every clearance here is in the API, with alerts when new ones post.